On Monday, 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) opened lower -4.63% from the last session, before settling in for the closing price of $0.52. Price fluctuations for SXTP have ranged from $0.45 to $8.00 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 12.29% over the past five years. Company’s average yearly earnings per share was noted 84.04% at the time writing. With a float of $4.10 million, this company’s outstanding shares have now reached $4.10 million.
60 Degrees Pharmaceuticals Inc (SXTP) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 60 Degrees Pharmaceuticals Inc is 3.19%, while institutional ownership is 1.01%. The most recent insider transaction that took place on Dec 15 ’25, was worth 7,759. In this transaction President and CEO of this company bought 9,670 shares at a rate of $0.80, taking the stock ownership to the 59,618 shares. Before that another transaction happened on Dec 10 ’25, when Company’s President and CEO bought 9,350 for $0.95, making the entire transaction worth $8,886. This insider now owns 46,335 shares in total.
60 Degrees Pharmaceuticals Inc (SXTP) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -8.48 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -3.25) by -5.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 70.24% during the next five years compared to 12.29% growth over the previous five years of trading.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Trading Performance Indicators
Check out the current performance indicators for 60 Degrees Pharmaceuticals Inc (SXTP). In the past quarter, the stock posted a quick ratio of 2.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.32, a number that is poised to hit -0.57 in the next quarter and is forecasted to reach -1.73 in one year’s time.
Technical Analysis of 60 Degrees Pharmaceuticals Inc (SXTP)
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) saw its 5-day average volume 0.54 million, a positive change from its year-to-date volume of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 14.04%.
During the past 100 days, 60 Degrees Pharmaceuticals Inc’s (SXTP) raw stochastic average was set at 3.02%, which indicates a significant decrease from 9.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0696 in the past 14 days, which was lower than the 0.0838 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0141, while its 200-day Moving Average is $1.7144. Nevertheless, the first resistance level for the watch stands at $0.5296 in the near term. At $0.5673, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.5945. If the price goes on to break the first support level at $0.4647, it is likely to go to the next support level at $0.4375. The third support level lies at $0.3998 if the price breaches the second support level.
60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) Key Stats
There are currently 4,230K shares outstanding in the company with a market cap of 2.08 million. Presently, the company’s annual sales total 680 K according to its annual income of -7,950 K. Last quarter, the company’s sales amounted to 530 K and its income totaled -2,320 K.
